EP 3 – Article Of The Week: Exenatide once a week versus placebo as a potential disease modifying treatment for people with Parkinsons disease in the UK: a phase 2, multi centre, double-blind, parallel-group, randomised, placebo-controlled trial

EP 3 – Article Of The Week: Exenatide once a week versus placebo as a potential disease modifying treatment for people with Parkinsons disease in the UK: a phase 2, multi centre, double-blind, parallel-group, randomised, placebo-controlled trial

 🎙️ We’re back with the third episode of Parkinson Weekly, hosted by Prof. Bas Bloem. This week’s Article of the Week explores an exciting area of research: “Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson’s...